Green Thumb Industries (GTBIF) EPS (Diluted) Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) EPS (Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -35.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.53% |
| Mar 31, 2026 | 17.94% |
| Dec 31, 2025 | 61.29% |
| Sep 30, 2025 | 33.67% |
| Jun 30, 2025 | -68.98% |
| Mar 31, 2025 | -34.22% |
| Dec 31, 2024 | -9.28% |
| Sep 30, 2024 | -26.68% |
| Jun 30, 2024 | -5.59% |
| Mar 31, 2024 | 36.10% |
| Dec 31, 2023 | 49.19% |
| Sep 30, 2023 | -3.60% |
| Jun 30, 2023 | 44.62% |
| Mar 31, 2023 | 61.24% |
| Dec 31, 2022 | -74.84% |
| Sep 30, 2022 | 37.67% |
| Jun 30, 2022 | 26.43% |
| Mar 31, 2022 | 26.64% |